74 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
; Financial Statements; Financial Condition; No Material Adverse Change; Books and Records
Solvency
Payment of Taxes
Environmental Matters
Material … or Acquisition of Subsidiaries
Post-Closing Requirements
Environmental
Inventory; Returns; Maintenance of Properties
Regulatory Obligations; Maintenance
8-K
EX-2.1
q4i5 ru7b1co003o1oe
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
nei6fzf7h42 6ezntkb0
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
rvgy0z05
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
vgz3swvx400roq69g
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
zbt52sf
16 Jun 23
Business combination disclosure
8:08am
425
yb0d qa8lhxhak9o
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
egb34l2skcz
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
zorgb68r
18 May 23
Other Events
5:02pm